Table 7.
Advice for the use of CCT and CMR in ischaemic VT ablation procedures | Strength of advice | Imaging modality | CT specifications | MR specifications |
---|---|---|---|---|
(1) Pre-procedural imaging is advised to rule out intracavitary ventricular thrombus | CMR or CCT | i.v. contrast injection and imaging in arterial and delayed phase | Early and late gadolinium enhancement sequences/LGE, steady-state free precession sequence (cine) | |
(2) Pre-procedural imaging may be appropriate to determine scar location | CMR or CCT | i.v. contrast injection and late iodine enhancement | LGE | |
(3) Pre-procedural imaging may be appropriate to determine scar transmurality | CMR or CCT | i.v. contrast injection and late iodine enhancement | LGE | |
(4) Pre-procedural imaging (CMR) may be appropriate to determine core–border zone transition | CMR | — | LGE | |
(5) Post-processing of imaging-derived scar (VT substrate) and integration into 3D mapping system may be appropriate to aid or guide VT ablation | CMR or CCT | i.v. contrast injection arterial phase and late iodine enhancement | LGE |
CCT, cardiac computed tomography; CT, computed tomography; CMR, cardiac magnetic resonance imaging; LGE, late gadolinium enhancement; MR, magnetic resonance; VT, ventricular tachycardia.